The focus on genomics continues:
London is hosting another key conference exploring the opportunities and advances in the biotechnology sector. The event has been organised by Oxford Global – and Future Genetics have been asked to chair the main-stage panel discussion on genomics.
Key speakers from leading companies have been invited to speak at this event.
The CEO and Medical Director of Future Genetics has been invited to chair an specialist panel discussion titled “Accelerating the Genomics Revolution“.
Dr Kamran will moderate this highly anticipated session, where the panel will comprise of Ms Sowmiya Moorthie who is a Senior Policy Analyst at the PHG Foundation, Tommi Lehtonen (CEO, Blueprint Genetics) and Mr Ali Mortazavi (CEO, Silence Therapeutics).
The areas covered in the discussion will be:
- Adoption of Next Generation Sequencing (NGS)
- Moving to single-cell biology
- Clinical Diagnostics
- cell-free DNA
The event is being held in Covent Garden London:
De Vere Grand Connaught Rooms
61-65 Great Queen St
Tel: 020 7405 7811
The two-day conference consists of an educational programme that includes over 60 presentations, postulating topics on scientific, technological and investment growth in the industry.The 2018 Biotech Investment showcase is the UK and Europe’s most focused and leading-edge funding, investment and partnering forum in the biotech sector, hosting over 200 attendees.
Please view the full agenda by clicking the below link:
Leading Venture Capitalists, funds, investors, hedge funds, emerging successful biotech spinoffs, early stage biotech discovery and clinical companies and KOLs in the sector will be attending this one of a kind showcase event on the 22nd & 23rd May 2018 in London.
It is anticipated that the event will help to identify the key technological and scientific investment areas.
The event is being sponsored by:
For more Information about the event contact Oxford Globat at: www.biotechinvestment-showcase.com